American National Bank & Trust’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-941
Closed -$12.9K 574
2023
Q3
$12.9K Hold
941
﹤0.01% 391
2023
Q2
$13.3K Sell
941
-105
-10% -$1.52K ﹤0.01% 387
2023
Q1
$15.4K Hold
1,046
﹤0.01% 372
2022
Q4
$16K Sell
1,046
-184
-15% -$2.79K ﹤0.01% 349
2022
Q3
$17K Hold
1,230
﹤0.01% 325
2022
Q2
$19K Hold
1,230
﹤0.01% 253
2022
Q1
$20K Sell
1,230
-770
-39% -$12.9K ﹤0.01% 265
2021
Q4
$36K Buy
+2,000
New +$34.9K 0.01% 208

Other funds holding DIAX

American National Bank & Trust's DIAX Position: Q4 2023 in Review

American National Bank & Trust sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q4 2023, closing a stake of 941 shares — an estimated $12.9K sold.

American National Bank & Trust first reported a position in DIAX in Q4 2021 and held it in 8 quarters. The position peaked at $36K in Q4 2021. 82 funds tracked by Wall St. Rank hold DIAX as of Q4 2023.

  • American National Bank & Trust reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q4 2023 after selling out during the quarter.
  • American National Bank & Trust sold 941 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q4 2023, an estimated $12.9K.
  • American National Bank & Trust first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2021 and held it in 8 quarters.
  • American National Bank & Trust's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $36K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q4 2023.

Based on American National Bank & Trust's 13F filing for Q4 2023, filed 8 Feb 2024.